Who We Are

Protean Capital is an independent asset manager and adviser with deep expertise in defined return investments and quantitative strategies. Founded in 2012, our goal is to deliver innovation and value to clients while maintaining a clear focus on the risks taken and cost-efficient implementation.

We specialise in strategies that carry significantly lower risk than conventional equity investments, but which provide most of the returns expected from equities. We maintain a rigorous focus on risk, investment rationale and economic value.

Our strategies provide attractive alternatives to investments in conventional asset classes, and are designed to boost the stability and efficiency of a wide range of investment portfolios and risk categories.

We develop and implement investment strategies, including the VT Protean Capital ELDeR Fund, as well as customised solutions for investment managers, family offices and institutional investors.

Our team draws on extensive experience in all aspects of the investment process, from conception through to execution, secondary market activity and redemption, to deliver tailored solutions for each client.

The Managing Partners

  • Bob Champney

    A published research mathematician, Extel and Reuters rated #1 analyst (for three consecutive years), exotic derivatives trader and hedge fund manager, Bob is widely considered to be a thought leader in the financial community. Former Merrill Lynch MD and Treasury Select Committee advisor, Bob has been at the forefront of research, product development and fund management in the UK for over 30 years.

    Bob has considerable experience of coal-face asset management, having run multi-asset hedge portfolios of well over EUR 8Bn AUM. Bob is often asked to provide his expert opinion, appearing on both BBC TV and BBC Radio as well as in the financial media, and has written many articles for the FT and Risk Magazine. Bob now maintains a lower profile, focusing solely on Protean’s client base.

    Bob’s strong academic background, allied with his long-standing experience in the trading and hedge fund community, enable him to deliver (to a broader investor base) products specifically designed to access and exploit the macro economic strategies of today’s top flight institutional fund and investment managers.

  • Mike Egerton

    Mike started his career in retail banking where he was responsible for fixed income trading, product development and balance sheet risk management. From here he was recruited to the equity-linked product group at Merrill Lynch where he spent seven years before moving to head the UK & Ireland derivative product teams at Deutsche, DrKW and ABN AMRO.

    Mike has always been at the forefront of new investment concepts and has a uniquely broad and deep expertise in the underlying derivatives, implementation and UK regulatory and taxation environment. He is a proven innovator and has been behind a number of industry-leading delivery vehicles.

    With clients ranging from family offices and wealth managers to pension funds and insurance companies, Mike is aware of the many issues facing both High Net Worth and institutional investors.